News FDA approves new uses for two Roche drugs FDA hands out new indications for Tecentriq and Lucentis.
News Opdivo still clear immunotherapy leader despite Keytruda gai... Immunotherapy takes on rivals from Roche and BMS.
News Roche's Tecentriq approved for UK early access Tecentriq is latest immunotherapy available on the scheme.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Cancer Positive results for Pacific Edge's bladder cancer diagnosti... Cancer diagnostic company Pacific Edge has revealed positive trial results for its Cxbladder Monitor gene expression test.
Views & Analysis Pharma gets social: did digital opinion leaders shape NICE g... Digital Opinion Leaders as activists in healthcare decision making.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.